At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy
In Brief
A Phase 2 clinical trial evaluating HTX-011, Placebo, and 5 other interventions for Postoperative Pain. Completed, enrolled 463 participants across 3 sites.
Detailed Summary
A Phase 2, Randomized, Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy
Study Details
Timeline
Interventions
HTX-011 (bupivacaine/meloxicam) by injection.
Saline placebo by injection.
HTX-002, by injection or instillation (pooled).
Bupivacaine HCI (Marcaine) by injection.
HTX-011A (bupivacaine/meloxicam) by injection.
HTX-011B (bupivacaine/meloxicam) by injection, instillation or combination.
HTX-009 by injection and instillation (combination).